Background: Cardiac Implantable Electronic Devices (CIEDs) leads may fail or require deactivation for other reasons. These leads can either be abandoned or extracted, but there is a paucity of long-term outcome data comparing these two management strategies. We present a cohort of patients who underwent either lead abandonment or extraction with long-term outcome data.
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Methods: We conducted a retrospective review of all consecutive patients with an endocardial lead abandoned or extracted at Wellington Hospital between February 1992 and 2018. Clinical notes were reviewed for pre-defined outcomes including lead failure, endocarditis, inappropriate therapy, failure of therapy, venous complications and mortality.
Results: A total of 514 deactivated leads in 382 patients were identified; 326 were abandoned, 182 extracted and 6 partially extracted. Atrial leads abandoned due to permanent atrial fibrillation (n = 122) were excluded from the statistical analysis.
Patients who underwent lead extraction tended to be younger (58 ± 16 vs. 72 ± 13 years, p < 0.01) and have a lower incidence of hypertension (36% vs. 57%, p < 0.01), diabetes (11% vs. 19%, p = 0.04) and atrial fibrillation (38% vs. 53%, p < 0.01). Event rates were similar between abandoned and extracted lead management groups; endocarditis (0.6% vs. 0.9%, p = 0.80), venous thrombosis (3.0% vs. 0.7%, p = 0.56), compromised venous access (2.4% vs. 2.6%, p = 0.92), inappropriate therapy (1.2% vs. 2.6%, p = 0.38) or failure of therapy (0.6% vs. 2.6%, p = 0.16).
Conclusions: Patients with an indication for lead abandonment or extraction should be discussed at a CIED multi-disciplinary meeting to establish the optimal management strategy. Patients assessed in this fashion have similar long-term outcomes irrespective of management strategy. Methods: Consecutive STEMI patients (n = 119) with Day 3-5 left ventricular ejection fraction ≤40% underwent EPS to determine need for an early primary prevention implantable cardiac defibrillator (ICD). A positive EPS was defined as sustained monomorphic VT with cycle length (CL) ≥200 ms. The induced VT was terminated by overdrive pacing or DC shock at 30 seconds or earlier if haemodynamic decompensation occurred. A negative EPS was defined as no arrhythmia induced or inducible ventricular fibrillation/flutter at CL <200 ms. All patients with inducible VT received primary prevention ICD, except for 6 patients, who declined.
Results: 116 patients were analysed. Data were not available for 3 patients. The mean age was 58.6 ± 11.2 years with 105 males and 14 females. The mean LVEF was 30.5 ± 7%. Follow up was 4.9 ± 3.8 years. 8 patients were lost to follow up. Those with duration of induced VT of 0-10 seconds were compared to those with >10 seconds. VT recurrence rates 32% in the 0-10 seconds and 19% in the >10 seconds group.
Conclusion: This study is the first to show that median durations of inducible VT of 4 and 20 seconds at EPS early after STEMI have similar prognostic value. Furthermore, even inducible VT that lasted <10 seconds has predictive power for VT recurrence on follow up. http://dx.doi.org/10. 1016/j.hlc.2019.06.182 
